{"id":483891,"title":"Summary report of the Drug Good Manufacturing Practices (GMP) Inspection Program - April 1, 2006 to March 31, 2011 - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T22:36:02.983000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/summary-report-drug-good-manufacturing-practices-inspection-program.html","snippet":"Summary report of the Drug Good Manufacturing Practices (GMP) Inspection Program - April 1, 2006 to March 31, 2011 (PDF Version - 225 K) Contact Information Our Mandate: To manage and deliver a national compliance and enforcement program for blood and donor semen; cells, tissues…","rawSnapshotUrl":"/api/snapshots/raw/483891","browseUrl":"https://replay.healtharchive.ca/job-6/20260106223602/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/summary-report-drug-good-manufacturing-practices-inspection-program.html#ha_snapshot=483891","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}